China NMPA Product Recall - Blood gas analyzer

On May 22, 2020, Radomet Medical Equipment (Shanghai) Co., Ltd. initiated a voluntary Class II recall of its blood gas analyzers. This action was taken in response to a critical product issue where, under specific operational settings and event sequences, measurement results for one patient could be incorrectly attributed to another. This potential misassignment of patient data poses a significant risk to patient safety and the accuracy of medical diagnoses. The recall was reported through the Shanghai Municipal Drug Administration Website and subsequently publicized by the National Medical Products Administration (NMPA), the primary regulatory body overseeing medical devices. Although specific inspection dates were not provided, the recall notification was officially published on the aforementioned date. The required action involves a voluntary Class II recall, indicating a situation where the use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences. The company is expected to provide detailed information on affected models, specifications, and batch numbers in a "Medical Device Recall Event Report Form" to facilitate comprehensive corrective measures.